Daily Anesthesiology Research Analysis
Analyzed 93 papers and selected 3 impactful papers.
Summary
Three impactful anesthesiology studies stood out: a novel real-time cerebral autoregulation index validated in surgical patients and animals; a multicenter, externally validated perioperative AKI risk model ready for clinical use; and a randomized trial showing high‑flow nasal oxygen improves fetal acid–base status during elective cesarean delivery. Together, these works advance perioperative monitoring, risk stratification, and obstetric anesthetic care.
Research Themes
- Autoregulation-guided intraoperative monitoring
- Perioperative risk prediction and AKI prevention
- Obstetric anesthesia and fetal acid–base optimization
Selected Articles
1. A Novel Algorithm for Continuous Real-Time Cerebral Autoregulation Assessment Based on Mean Arterial Pressure and Cerebral Oxygen Saturation.
Using only MAP and cerebral StO2, the CAI algorithm accurately classified impaired versus intact cerebral autoregulation in 71 surgical patients (AUC 0.92) and 10 piglets (AUC 0.99). This enables real-time, individualized, autoregulation-guided blood pressure management during surgery.
Impact: This is a methodological advance with direct perioperative applicability, potentially reducing cerebral hypoperfusion or hyperperfusion by keeping MAP within individualized autoregulatory limits.
Clinical Implications: Autoregulation-index–guided titration of vasoactive therapy and BP targets could personalize intraoperative management. Integration into monitors could alert clinicians when MAP drifts beyond each patient’s LLA/ULA.
Key Findings
- In 71 surgical patients, CAI discriminated impaired vs intact autoregulation with AUC 0.92 (sensitivity 0.82, specificity 0.94 at threshold 45).
- In 10 piglets with controlled hypotension, CAI achieved AUC 0.99 (sensitivity 0.95, specificity 0.96).
- Ground truth autoregulation status was defined by individualized LLA/ULA from CBF/CBFV–MAP curves.
Methodological Strengths
- Multicenter prospective human dataset plus controlled animal validation
- Physiological ground truth labeling via individualized LLA/ULA from CBF/CBFV–MAP relationships with ROC benchmarking
Limitations
- Algorithm validated via postprocessing; real-time clinical integration and outcome impact not yet tested
- Relies on NIRS-derived StO2, which can be affected by extracerebral signals and device variability
Future Directions: Prospective interventional trials testing CAI-guided MAP targets on neurological outcomes; device integration and robustness across NIRS platforms; validation in high-risk populations (e.g., cardiac surgery, neurosurgery).
BACKGROUND: Continuous and real-time assessment of cerebral autoregulation can be of important clinical value to individualize blood pressure targets in perioperative settings. There is a high interindividual variability of the lower (LLA) and upper (ULA) limits of cerebral blood flow autoregulation, and exposure to blood pressure values outside of these limits has been associated with complications. We have developed a novel algorithm for continuous real-time assessment of cerebral autoregulation based on analysis of the dynamic interactions of mean arterial pressure (MAP) and near-infrared spectroscopy cerebral oxygen saturation (Sto2) measurements. The algorithm generates an index, the cerebral autoregulation index (CAI), which characterizes the effectiveness of cerebral autoregulation on a 0 to 100 scale. The aim of this study is to validate the algorithm using data from animals and surgical patients. METHODS: MAP, cerebral Sto2, and cerebral laser-Doppler blood flow (CBF) data were collected as part of an animal study on a piglet model of controlled hypotension. Additionally, simultaneous MAP, cerebral Sto2, and transcranial Doppler cerebral blood flow velocity (CBFV) data were collected on patients in a multicenter prospective observational study during surgery. Individual plots of CBF/CBFV versus MAP were constructed retrospectively for both the animal and human data, and ground truth labels of cerebral autoregulation status were obtained by identifying on these curves the LLA and ULA values. CAI values were generated by postprocessing MAP and cerebral Sto2 data through the algorithm. Receiver operating characteristic (ROC) analysis was then conducted to assess the capability of the algorithm to discriminate impaired autoregulation, where MAP is beyond the individual LLA/ULA limits, from intact autoregulation, where MAP is between LLA and ULA. RESULTS: Seventy-one patients were enrolled in the human study, and the ROC analysis showed an area under the ROC curve (AUC) (95% confidence interval) of 0.92 (0.89-0.94), with a sensitivity and specificity of 0.82 (0.76-0.87) and 0.94 (0.92-0.96), respectively, at the CAI threshold of 45. In addition, 10 female piglets underwent a controlled hypotension protocol where MAP was lowered below the LLA. The ROC analysis showed an AUC of 0.99 (0.98-1.00), with a sensitivity and specificity of 0.95 (0.90-0.99) and 0.96 (0.94-0.98), respectively. CONCLUSIONS: The study demonstrates that the CAI algorithm, using MAP and processed Sto2 signals, is accurate in discriminating states of intact autoregulation from states of impaired autoregulation. This algorithm may allow for personalized cerebral autoregulation-oriented blood pressure management during surgery.
2. Multicenter validation of a severity index model for predicting postoperative acute kidney injury.
A simple, clinically deployable SIM-AKI model predicted overall and critical postoperative AKI with good discrimination (development C 0.801/0.838; external 0.742–0.805) and calibration across three independent hospitals. Decision curve analysis supported potential clinical utility.
Impact: This externally validated model enables perioperative teams to stratify AKI risk at scale using routinely available data, informing preventive strategies and resource allocation.
Clinical Implications: Implement SIM-AKI in preoperative clinics and intraoperative dashboards to identify high-risk patients for renal-protective measures (hemodynamic optimization, nephrotoxin avoidance, early nephrology consult).
Key Findings
- Development cohort (n=191,938) C-statistics: overall AKI 0.801; critical AKI 0.838.
- External validation across three hospitals (n=118,047; 86,092; 3,727) showed C-statistics 0.742–0.759 (overall) and 0.767–0.805 (critical) with good calibration.
- Predictors included demographic, comorbidity, surgical, laboratory, and intraoperative variables selected via LASSO with bootstrap stability checks.
Methodological Strengths
- Very large development cohort with three independent external validations
- Rigorous variable selection (LASSO, cross-validation, bootstrap) with calibration and decision-curve analyses
Limitations
- Retrospective EHR-based modeling; prospective impact on outcomes not tested
- Model performance may vary with data quality and case-mix outside tertiary centers
Future Directions: Prospective implementation studies with clinical decision support to test whether SIM-AKI–guided care reduces AKI incidence and severity; adaptation to cardiac surgery and ICU settings.
BACKGROUND: Existing models for predicting postoperative acute kidney injury (AKI) after non-cardiac surgery are often complex and insufficiently validated for broad clinical use. We developed and externally validated a simple yet accurate model for predicting both overall and critical AKI that can be readily applied in routine practice. METHODS: The severity index model for AKI (SIM-AKI) was developed using data from 191,938 patients undergoing non-cardiac surgery at a tertiary hospital and externally validated using three independent datasets from other tertiary hospitals (n = 118,047; 86,092; 3727). Variables were selected using least absolute shrinkage and selection operator regression with 10-fold cross-validation, and predictor stability was assessed using backward elimination across 100 bootstrap resamples before multinomial logistic regression modeling. Model performance was evaluated using the C-statistic for discrimination, calibration plots, Brier scores, and decision curve analysis (DCA) for clinical utility. RESULTS: The SIM-AKI model incorporated age, sex, diabetes mellitus, American Society of Anesthesiologists classification, cancer surgery, emergency status, major abdominal surgery, anemia, hypoalbuminemia, estimated glomerular filtration rate, intraoperative transfusion, and operation time. For overall AKI, C-statistics were 0.801 (95% CI 0.796-0.806) in development and 0.754, 0.742, and 0.759 in validation cohorts. For critical AKI, C-statistics were 0.838 (95% CI 0.826-0.850) in development and 0.796, 0.805, and 0.767 in validation cohorts, demonstrating good calibration and clinical benefit in DCA. The SIM-AKI compared favorably with existing AKI prediction models in discrimination. CONCLUSION: SIM-AKI may serve as a reliable perioperative tool for predicting the risk of both overall and critical postoperative AKI in patients undergoing non-cardiac surgery.
3. Effect of maternal oxygen supplementation for parturients undergoing elective cesarean delivery by high‑flow nasal oxygen compared with room air on fetal acid-base status: a randomized clinical trial.
In 112 women undergoing elective cesarean delivery, high‑flow nasal oxygen (40 L/min, FiO2 1.0) lowered umbilical artery lactate and increased pH and PaO2 versus room air, without worsening oxidative stress or Apgar scores. This supports the safety and physiological benefit of HFNO during cesarean.
Impact: Provides randomized evidence that maternal HFNO can improve fetal acid–base status during cesarean without short‑term harm, informing oxygen supplementation strategies in obstetric anesthesia.
Clinical Implications: HFNO may be considered to optimize fetal oxygenation during cesarean under neuraxial anesthesia, with attention to maternal oxygen targets and institutional protocols.
Key Findings
- HFNO reduced umbilical artery lactate (1.60 vs 1.80 mmol/L; P=0.003) and increased pH (7.32 vs 7.31; P=0.004).
- HFNO improved umbilical artery PaO2 (17.34±3.73 vs 15.67±3.36 mmHg; P=0.022) and reduced PaCO2 (P=0.003).
- No differences in Apgar scores or oxidative stress markers between groups.
Methodological Strengths
- Randomized allocation with prespecified primary outcome and clinical trial registration
- Clinically relevant fetal acid–base endpoints with concurrent oxidative stress assessment
Limitations
- Single-period peri-delivery assessment without long-term neonatal outcomes
- Use of 100% oxygen may limit generalizability to titrated FiO2 strategies; blinding unlikely
Future Directions: Trials in higher-risk pregnancies and protocolized FiO2 titration to maternal targets, assessing neonatal long-term neurodevelopment and maternal cardiopulmonary safety.
BACKGROUND: High-flow nasal oxygen may offer benefits for maternal during cesarean delivery. However, its effects on fetal acid-base status remain understudied. The objective of this study was to determine if high-flow nasal oxygen improves fetal acid-base outcomes compared to room air in patients undergoing elective cesarean delivery under combined spinal-epidural anesthesia. METHODS: Patients undergoing elective cesarean delivery, gestation age of at least 37 weeks, age between 18 and 45 were eligible. Participants were randomly assigned 1:1 to receive either high-flow nasal oxygen at 40 L/min with 100% oxygen or room air at 2 L/min after epidural catheter placement until delivery. The primary outcome was umbilical artery lactate level. Secondary outcomes included umbilical artery pH, partial pressure of oxygen, partial pressure of carbon dioxide, Apgar scores, and oxidative stress markers. RESULTS: Between July to December 2023, 112 completed the study protocol. The high-flow nasal oxygen group had significantly lower umbilical artery lactate levels (1.60 [1.30-1.80] mmol/L vs. 1.80 [1.50-2.30] mmol/L; P = 0.003) and higher umbilical artery pH (7.32 [7.30-7.35] vs. 7.31 [7.28-7.33]; P = 0.004). The high-flow nasal oxygen group also showed improved umbilical artery partial pressure of oxygen (17.34 ± 3.73 vs. 15.67 ± 3.36 mmHg; P = 0.022) and lower partial pressure of carbon dioxide (50.10 [46.50-53.10] vs. 52.60 [48.35-56.65] mmHg; P = 0.003). No significant differences were observed in Apgar scores, oxidative stress markers, or other short-term neonatal outcomes between groups. CONCLUSIONS: High-flow nasal oxygen during elective cesarean delivery under combined spinal epidural anesthesia appears to improve fetal acid-base status and oxygenation without increasing oxidative stress. These findings emphasize that high-flow nasal oxygen does not adversely affect feta acid-base status, supporting its safety profile in low-risk pregnancies. This safety signal provides a rationale for further studies in higher-risk maternal populations. TRIAL REGISTRATION: This study is registered at ClinicalTrials.gov with the registration ID: NCT05921955.